Bone Stimulator for Spondylolysis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-40
SponsorThe Methodist Hospital Research Institute
About this trial
This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.
Eligibility criteria
Qualifiers
Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
Patients who plan to attend prescribed physical therapy
Patients who participate in a regular sport whether that be professional, collegiate or recreational
Disqualifiers
Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
Patients with contraindications to bone stimulator therapy
Patients with pacemaker and implantable cardioverter defibrillator
Patients with previous spine surgery
Trial design
Treatments tested in this trial
- Bone Stimulator
- Standard of Care Spondylolysis Treatment
Treatment groups
48 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov